Coronapod: Waiving vaccine patents and coronavirus genome data disputes
Listen now
In surprise news this week, the US government announced its support for waiving patent protections for COVID-19 vaccines, in an effort to boost supplies around the world.As fewer than 1% of people living in low-income countries have received COVID-19 vaccines, it is hoped that this move is a major step towards addressing this inequity by allowing manufacturers to legally produce generic versions of vaccines. We discuss the next steps that need to be taken to make this a reality, and why there is opposition to the plan. Also on the podcast, we look at another aspect of coronavirus inequity: the sharing of genomic data. Around the world, researchers are racing to upload SARS-CoV-2 genome sequences to repositories, to help in the fight against the pandemic. One popular data repository, GISAID, requires users to sign in and acknowledge those whose data they analyse. Although a growing faction of scientists from wealthy nations are calling for the removal of gatekeeping requirements, scientists in the global south are pushing back, arguing that this will deprive them of credit and chances to participate in big-data analyses. News: In shock move, US backs waiving patents on COVID vaccines News: Why some researchers oppose unrestricted sharing of coronavirus genome data News: Scientists call for fully open sharing of coronavirus genome data Science: Coronavirus sequence trove sparks frustration New York Times: Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine Washington Post: Poor countries may not be vaccinated until 2024. Here’s how to prevent that.  Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.   See for privacy and opt-out information.
More Episodes
Australian scientists are developing new technologies to help protect coral from climate change.   See for privacy and opt-out information.
Published 09/27/21
Less than 1% of those in low income countries are fully vaccinated, and that number only rises to 10% in low-middle income countries. Meanwhile more than half of the population in wealthier countries have received a double dose with several now rolling out third dosess. In this episode...
Published 09/25/21
How tiny seed-like sensors could monitor the environment, and the latest from the Nature Briefing.   See for privacy and opt-out information.
Published 09/22/21